微生物検査市場規模、シェア、動向、2031年までの世界予測

世界の微生物検査市場は、2026年の77億9,000万米ドルから2031年には100億9,000万米ドルに達し、予測期間中に5.3%の年平均成長率（CAGR）で成長すると予測されています。食品、水、環境分野における汚染リスクの高まり、工業生産の増加、検査技術の進歩により、市場は急速に成長すると見込まれています。汚染管理、規制遵守、製品安全性への関心の高まりに加え、迅速検査と自動化における革新により、正確で信頼性の高い微生物検査ソリューションへの需要が高まっています。しかしながら、高度な検査システムのコストや低コストソリューションのばらつきに対する懸念が、市場の成長を抑制する可能性があります。とはいえ、検査方法の継続的な改善と、様々な業界での導入増加が相まって、市場拡大を促進すると予想されます。

調査範囲

本レポートは、微生物検査市場を製品、技術、病原体の種類、エンドユーザー、地域別に分析しています。また、市場の成長に影響を与える主要要因（促進要因、阻害要因、機会、課題）を分析するとともに、市場リーダー間の競争環境を詳細に分析しています。さらに、本レポートでは、マイクロ市場を個々の成長傾向に基づいて分析しています。さらに、5つの主要地域（および各地域内の各国）における市場セグメントの収益予測も行っています。

レポートを購入する理由

本レポートは、既存企業だけでなく、新規参入企業も市場の動向を把握し、市場シェアの拡大に役立てることができます。本レポートを購入した企業は、以下に挙げる戦略のいずれか、あるいは複数を活用することで、市場におけるプレゼンスを強化できます。

本レポートでは、以下の点について洞察を提供します。

• 主要な推進要因の分析（迅速な微生物検査における技術の進歩、研究開発費の増加、不適合食品による食品リコールの増加、化粧品・パーソナルケア業界からの需要の増加）、制約要因（検査技術の複雑さ、多額の資本投資、低い費用対効果）、機会（デジタルおよび自動検査プラットフォームの普及、検査業界における技術の進歩）、課題（運用上の障壁、微生物検査機器の調達コストの上昇）
• 市場浸透：微生物検査市場における主要企業が提供する製品ポートフォリオに関する包括的な情報
• 製品開発／イノベーション：微生物検査市場における今後のトレンド、研究開発活動、製品発売に関する詳細な洞察
• 市場開発：収益性の高い新興地域に関する包括的な情報
• 市場多様化：微生物検査市場における新製品、成長地域、最近の動向に関する網羅的な情報
• 競合評価：bioMérieux（フランス）、Thermo Fisher Scientific Inc.（米国）、Merck KGaA（ドイツ）、Becton, Dickinson and Company（米国）、Neogen Corporation（米国）など、主要市場企業の市場セグメント、成長戦略、収益分析、製品に関する詳細な評価

Report Description

The global microbiology testing market is projected to reach USD 10.09 billion by 2031, up from USD 7.79 billion in 2026, at a CAGR of 5.3% during the forecast period. The market is expected to grow rapidly due to rising contamination risks in the food, water, and environmental sectors, increased industrial production, and advances in testing technologies. A growing focus on contamination control, regulatory compliance, and product safety, along with innovations in rapid testing and automation, is driving demand for accurate and reliable microbiology testing solutions. However, concerns about the cost of advanced testing systems and variability in low-cost solutions may restrain market growth. Nonetheless, continuous improvements in testing methodologies, coupled with increasing adoption across various industries, are expected to fuel market expansion.

The pharmaceutical & biotech companies segment is expected to have the largest market during the forecast period.

By end user, the market is segmented into pharmaceutical & biotech companies, food & beverage companies, environmental & water testing, cosmetics & personal-care companies, and other end users. In 2025, pharmaceutical & biotech companies accounted for the largest share of the market. The pharmaceutical & biotech segment is the largest in the microbiology testing market due to the critical need for contamination control, product safety, and regulatory compliance across drug manufacturing and biotechnological research. These industries rely heavily on microbiological testing to ensure the sterility, quality, and safety of their products, particularly biologics, vaccines, and therapeutic compounds. Stringent regulatory requirements, such as those from the FDA and EMA, mandate rigorous microbial testing at every stage of production, from raw material validation to final product release. Furthermore, the growing prevalence of diseases and the need for new treatments and therapies continue to drive significant demand for microbiology testing solutions, making pharmaceutical & biotech companies the largest consumers of these services.

The bacterial products segment accounted for the largest market share in the microbiology testing market.

The microbiology testing market is segmented by pathogen type into bacterial, viral, fungal, and other pathogens. The bacterial segment is the largest within this category due to the widespread presence and impact of bacterial contamination across various industries. Bacteria are among the most common pathogens in contamination issues across sectors such as food and beverage, water treatment, and environmental monitoring. Their ability to cause spoilage, disease, and quality issues drives strong demand for bacterial testing to ensure product safety, regulatory compliance, and public health. Additionally, well-established, reliable methods for detecting and identifying bacterial pathogens, along with regulatory mandates, further strengthen the dominance of the bacterial segment in microbiology testing.

The Asia Pacific is expected to be the fastest-growing market for microbiology testing during the forecast period.

The global microbiology testing market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is the fastest-growing market in the microbiology testing sector, driven by rapid industrialization, rising healthcare investments, and a growing focus on contamination control across industries. The region is seeing strong growth in sectors such as food and beverage, water treatment, and environmental monitoring, all of which require extensive microbiological testing to ensure safety and regulatory compliance. Additionally, improving healthcare infrastructure, coupled with rising awareness of food safety and public health, is driving demand for testing solutions. Government initiatives and regulatory developments in countries such as China, India, and across Southeast Asia further support market growth, while the adoption of advanced and automated microbiology testing technologies helps streamline operations and improve accuracy. These factors collectively position Asia-Pacific as the fastest-growing market for microbiology testing.

North America is the leading market for microbiology testing, driven by a strong regulatory framework that creates high demand for testing to ensure product safety and compliance. The region is a leader in adopting advanced, automated testing solutions that improve efficiency and accuracy. Additionally, North America’s diverse industries, including pharmaceuticals, biotechnology, food, and water, continually require reliable microbiology testing. The region’s well-established healthcare and industrial infrastructure, combined with significant investments in research and development, further solidifies its position as the market leader.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
• Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the microbiology testing market are bioMérieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US).

Research Coverage

This report examines the microbiology testing market by product, technology, pathogen type, end user, and region. It also examines key factors (drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape among market leaders. Furthermore, the report analyzes micro-markets by their individual growth trends. It forecasts market segment revenue for five major regions (and the respective countries within each region).

Reasons to Buy the Report

The report will enable established firms and smaller entrants to gauge the market’s pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or more of the strategies listed below to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key Drivers (Technological advancements in rapid microbiology testing, Increased funding for R&D, Rising food recalls due to non-compliant food products, Rising demand from cosmetics & personal care industry) Restraints (Complexity in testing techniques, High Capital investments, and low cost benefit ratio) Opportunities (Popularity of digital and automated testing platforms, Technological advancements in the testing industry) Challenges (Operational barriers, Increasing cost of procuring microbiology testing equipment)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microbiology testing market
• Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the microbiology testing market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microbiology testing market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as bioMérieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US)

Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 31
1.3.2 INCLUSIONS AND EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 33
2 EXECUTIVE SUMMARY 34
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS SHAPING MARKET 35
2.4 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS 36
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 37
3 PREMIUM INSIGHTS 38
3.1 MICROBIOLOGY TESTING MARKET OVERVIEW 38
3.2 MICROBIOLOGY TESTING MARKET, BY PRODUCT 38
3.3 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY 39
3.4 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE 39
3.5 MICROBIOLOGY TESTING MARKET, BY END USER 40
3.6 MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
4 MARKET OVERVIEW 41
4.1 INTRODUCTION 41
4.2 MARKET DYNAMICS 41
4.2.1 DRIVERS 41
4.2.1.1 Technological advancements in rapid microbiology testing 41
4.2.1.2 Increased funding for R&D 42
4.2.1.3 Rising food recalls due to non-compliant food products 42
4.2.1.4 Rising demand from cosmetics & personal care industry 45
4.2.2 RESTRAINTS 45
4.2.2.1 Complexity in testing techniques 45
4.2.2.2 High Capital investments and low cost-benefit ratio 46
4.2.3 OPPORTUNITIES 46
4.2.3.1 Popularity of digital and automated testing platforms 46
4.2.3.2 Technological advancements in testing industry 46
4.2.4 CHALLENGES 47
4.2.4.1 Operational barriers 47
4.2.4.2 Increasing cost of procuring microbiology testing equipment 48
4.3 UNMET NEEDS AND WHITE SPACES 48
4.3.1 UNMET NEEDS IN MICROBIOLOGY TESTING MARKET 48
4.3.2 WHITE SPACE OPPORTUNITIES 49
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50
4.4.1 INTERCONNECTED MARKETS 50
4.4.2 CROSS-SECTOR OPPORTUNITIES 50
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 51
4.5.1 KEY MOVES AND STRATEGIC FOCUS 51
5 INDUSTRY TRENDS 52
5.1 PORTER’S FIVE FORCES ANALYSIS 52
5.1.1 THREAT OF NEW ENTRANTS 53
5.1.2 THREAT OF SUBSTITUTES 53
5.1.3 BARGAINING POWER OF BUYERS 53
5.1.4 BARGAINING POWER OF SUPPLIERS 54
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.2 MACROECONOMIC INDICATORS 54
5.2.1 INTRODUCTION 54
5.2.2 GDP TRENDS AND FORECAST 54
5.3 SUPPLY CHAIN ANALYSIS 57
5.4 VALUE CHAIN ANALYSIS 58
5.5 ECOSYSTEM ANALYSIS 59
5.6 PRICING ANALYSIS 61
5.6.1 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY PRODUCT 61
5.6.2 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS,
BY KEY PLAYER 61
5.6.3 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS,
BY REGION 62
5.7 TRADE ANALYSIS 63
5.7.1 IMPORT SCENARIO (HS CODE 3822) 63
5.7.2 EXPORT SCENARIO (HS CODE 3822) 63
5.8 KEY CONFERENCES & EVENTS, 2026–2027 64
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
5.10 INVESTMENT & FUNDING SCENARIO 65
5.11 CASE STUDY ANALYSIS 66
5.11.1 YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS 66
5.11.2 RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS 67
5.11.3 RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION 67
5.12 IMPACT OF 2025 US TARIFFS ON MICROBIOLOGY TESTING MARKET 68
5.12.1 INTRODUCTION 68
5.12.2 KEY TARIFF RATES 68
5.12.3 PRICE IMPACT ANALYSIS 69
5.12.4 KEY IMPACT ON COUNTRY/REGION 69
5.12.4.1 North America 69
5.12.4.2 Europe 69
5.12.4.3 Asia Pacific 69
5.12.5 IMPACT ON END-USE INDUSTRIES 70
5.12.5.1 Pharmaceutical & biotech companies 70
5.12.5.2 Food & beverage companies 70
5.12.5.3 Environmental & water testing 70
5.12.5.4 Cosmetics & personal care companies 70
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 71
6.1 KEY EMERGING TECHNOLOGIES 71
6.1.1 AUTOMATED MULTIPLEX PCR SYSTEMS 71
6.1.2 BIOSENSORS 71
6.2 COMPLEMENTARY TECHNOLOGIES 72
6.2.1 FOOD & WATER SAFETY MONITORING TOOLS 72
6.2.2 ANTIMICROBIAL RESISTANCE TESTING 72
6.3 TECHNOLOGY/PRODUCT ROADMAP 72
6.4 PATENT ANALYSIS 73
6.5 FUTURE APPLICATION 74
6.6 IMPACT OF AI/GENERATIVE AI ON MICROBIOLOGY TESTING MARKET 75
6.6.1 INTRODUCTION 75
6.6.2 TOP USE CASES AND MARKET POTENTIAL 75
6.6.3 USE CASE 76
6.6.3.1 Adoption of Gen AI by CarbConnect to achieve accuracy and consistency in diagnostics 76
6.6.4 EVOLVING ADJACENT ECOSYSTEM THROUGH ADOPTION OF GEN AI 76
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 78
7.1 REGIONAL REGULATIONS AND COMPLIANCE 78
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
7.1.2 INDUSTRY STANDARDS 80
7.2 SUSTAINABILITY INITIATIVES 81
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN MICROBIOLOGY TESTING 81
7.2.1.1 Eco-friendly initiatives 81
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 82
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 83
8.1 DECISION-MAKING PROCESS 83
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 83
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
8.2.2 BUYING CRITERIA 84
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 85
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 86
8.5 MARKET PROFITABILITY 87
8.5.1 REVENUE POTENTIAL 87
8.5.2 COST DYNAMICS 87
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 87
9 MICROBIOLOGY TESTING MARKET, BY PRODUCT 88
9.1 INTRODUCTION 89
9.2 INSTRUMENTS 89
9.2.1 WIDESPREAD ADOPTION OF AUTOMATED AND HIGH-THROUGHPUT LABORATORY INSTRUMENTS TO SUPPORT MICROBIOLOGY TESTING DEMAND 89
9.2.2 INCUBATORS 93
9.2.2.1 Controlled environmental conditions to enable reliable microbial growth and detection 93
9.2.3 MICROSCOPES 96
9.2.3.1 Direct visualization and morphological analysis of microorganisms 96
9.2.4 COLONY COUNTERS 98
9.2.4.1 Accurate enumeration of microbial colonies to support quality assurance 98
9.2.5 MASS SPECTROMETERS 100
9.2.5.1 Rapid and accurate microbial identification through advanced mass spectrometry methods 100
9.2.6 AUTOMATED CULTURE SYSTEMS 102
9.2.6.1 High-throughput systems supporting standardized microbiology workflows 102
9.2.7 OTHER INSTRUMENTS 105
9.3 REAGENTS & KITS 107
9.3.1 HIGH RECURRING DEMAND FOR STANDARDIZED AND READY-TO-USE REAGENTS & KITS TO SUPPORT MARKET GROWTH 107
9.4 CONSUMABLES 111
9.4.1 CONSISTENT HIGH-VOLUME CONSUMPTION OF DISPOSABLE LABORATORY SUPPLIES TO FUEL ROUTINE MICROBIOLOGY TESTING MARKET 111
10 MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS 116
10.1 INTRODUCTION 116
10.2 US: VOLUME OF PHARMA INCUBATOR INSTALLED BASE 116

11 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY 117
11.1 INTRODUCTION 118
11.2 TRADITIONAL MICROBIOLOGY METHODS (TMM) 118
11.2.1 WIDESPREAD REGULATORY ACCEPTANCE AND COST-EFFECTIVENESS TO SUPPORT CONTINUED ADOPTION 118
11.2.2 CULTURE METHODS 122
11.2.2.1 Continued reliance on culture-based techniques to support routine microbiology testing 122
11.2.3 MICROSCOPY METHODS 125
11.2.3.1 Rapid preliminary microbial screening to support contamination investigations 125
11.2.4 MANUAL COUNTING METHODS 127
11.2.4.1 Regulatory acceptance of plate count techniques to maintain widespread usage 127
11.2.5 STAINING TECHNIQUES 130
11.2.5.1 Low-cost and effective microbial differentiation methods to support quality control 130
11.2.6 OTHER TRADITIONAL MICROBIOLOGY METHODS 132
11.3 RAPID MICROBIOLOGY METHODS (RMM) 135
11.3.1 RAPID MICROBIOLOGY METHODS ENABLE FASTER CONTAMINATION DETECTION AND IMPROVED TESTING EFFICIENCY 135
11.3.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING 139
11.3.2.1 Growing demand for growth-based rapid microbiology testing to drive market growth 139
11.3.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING 142
11.3.3.1 High level of sensitivity, accuracy, and specificity associated with this method to boost market 142
11.3.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING 145
11.3.4.1 High accuracy associated with nucleic acid-based methods to favor market growth 145
11.3.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING 148
11.3.5.1 Near real-time detection and improved accuracy to drive demand 148
12 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE 152
12.1 INTRODUCTION 153
12.2 BACTERIAL 153
12.2.1 WIDESPREAD OCCURRENCE OF BACTERIAL CONTAMINATION ACROSS INDUSTRIES TO SUPPORT MARKET DOMINANCE 153
12.3 VIRAL 155
12.3.1 INCREASING FOCUS ON VIRAL SAFETY AND ENVIRONMENTAL SURVEILLANCE TO DRIVE SEGMENT GROWTH 155
12.4 FUNGAL 157
12.4.1 RISING INCIDENCE OF YEAST AND MOLD CONTAMINATION TO FUEL TESTING DEMAND 157
12.5 OTHER PATHOGENS 159
13 MICROBIOLOGY TESTING MARKET, BY END USER 162
13.1 INTRODUCTION 163
13.2 PHARMACEUTICAL & BIOTECH COMPANIES 163
13.2.1 STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND 163
13.3 FOOD & BEVERAGE COMPANIES 166
13.3.1 STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH 166
13.4 ENVIRONMENTAL & WATER TESTING 168
13.4.1 GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND 168
13.5 COSMETICS & PERSONAL CARE COMPANIES 171
13.5.1 MICROBIAL SAFETY AND PRODUCT STABILITY REQUIREMENTS TO SUPPORT MARKET GROWTH 171
13.6 OTHER END USERS 173
14 MICROBIOLOGY TESTING MARKET, BY REGION 177
14.1 INTRODUCTION 178
14.2 NORTH AMERICA 178
14.2.1 US 181
14.2.1.1 Increasing adoption of technologically advanced products in US to favor market growth 181
14.2.2 CANADA 183
14.2.2.1 Favorable environment for R&D to drive market 183
14.3 EUROPE 185
14.3.1 GERMANY 188
14.3.1.1 Increase in investments and funding by government to fuel market growth 188
14.3.2 UK 190
14.3.2.1 High prevalence of contaminated food to drive market 190
14.3.3 FRANCE 192
14.3.3.1 Rise in R&D expenditure to favor market growth 192
14.3.4 ITALY 194
14.3.4.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market 194
14.3.5 SPAIN 196
14.3.5.1 Water monitoring mandate to boost market growth 196
14.3.6 REST OF EUROPE 198
14.4 ASIA PACIFIC 200
14.4.1 CHINA 204
14.4.1.1 High-profile contamination events and export standards to propel market 204
14.4.2 JAPAN 206
14.4.2.1 Stringent safety laws and foodborne outbreaks to accelerate market 206
14.4.3 INDIA 208
14.4.3.1 Growth in private and public investments in healthcare systems to drive adoption of microbiology testing products 208
14.4.4 SOUTH KOREA 210
14.4.4.1 Increasing demand for infection control products to support market growth 210
14.4.5 AUSTRALIA 212
14.4.5.1 Increase in awareness about antimicrobial resistance to fuel market 212
14.4.6 REST OF ASIA PACIFIC 214
14.5 LATIN AMERICA 216
14.5.1 BRAZIL 218
14.5.1.1 Need for manufacturers to comply with ANVISA’s rules to drive demand 218
14.5.2 MEXICO 220
14.5.2.1 Expanding microbiology testing capacity through trade and food safety enforcement to drive market 220
14.5.3 REST OF LATIN AMERICA 222
14.6 MIDDLE EAST & AFRICA 224
15 COMPETITIVE LANDSCAPE 227
15.1 OVERVIEW 227
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 227
15.3 REVENUE ANALYSIS, 2022–2024 228
15.4 MARKET SHARE ANALYSIS, 2025 229
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 232
15.5.1 STARS 232
15.5.2 EMERGING LEADERS 232
15.5.3 PERVASIVE PLAYERS 232
15.5.4 PARTICIPANTS 232
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 234
15.5.5.1 Company footprint 234
15.5.5.2 Regional footprint 234
15.5.5.3 Product footprint 235
15.5.5.4 Technology footprint 235
15.5.5.5 End user footprint 236
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 237
15.6.1 PROGRESSIVE COMPANIES 237
15.6.2 RESPONSIVE COMPANIES 237
15.6.3 DYNAMIC COMPANIES 237
15.6.4 STARTING BLOCKS 237
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 239
15.6.5.1 List of startups/SMEs 239
15.6.5.2 Competitive benchmarking of startups/SMEs 239
15.6.5.2.1 Competitive benchmarking of startups/SMEs (1/2) 239
15.6.5.2.2 Competitive benchmarking of startups/SMEs (2/2) 240
15.7 COMPANY VALUATION AND FINANCIAL METRICS 240
15.8 BRAND/PRODUCT COMPARISON 241
15.9 COMPETITIVE SCENARIO 242
15.9.1 PRODUCT LAUNCHES AND APPROVALS 242
15.9.2 DEALS 243
15.9.3 EXPANSIONS 243
16 COMPANY PROFILES 244
16.1 KEY PLAYERS 244
16.1.1 BIOMÉRIEUX 244
16.1.1.1 Business overview 244
16.1.1.2 Products offered 245
16.1.1.3 Recent developments 246
16.1.1.3.1 Product launches and approvals 246
16.1.1.3.2 Deals 247
16.1.1.4 MnM view 248
16.1.1.4.1 Right to win 248
16.1.1.4.2 Strategic choices 248
16.1.1.4.3 Weaknesses and competitive threats 248
16.1.2 THERMO FISHER SCIENTIFIC INC. 249
16.1.2.1 Business overview 249
16.1.2.2 Products offered 250
16.1.2.3 Recent developments 251
16.1.2.3.1 Product launches & approvals 251
16.1.2.4 MnM view 251
16.1.2.4.1 Right to win 251
16.1.2.4.2 Strategic choices 252
16.1.2.4.3 Weaknesses and competitive threats 252
16.1.3 MERCK KGAA 253
16.1.3.1 Business overview 253
16.1.3.2 Products/Services offered 254
16.1.3.3 Recent developments 255
16.1.3.3.1 Product launches 255
16.1.3.3.2 Deals 255
16.1.3.3.3 Expansions 256
16.1.3.4 MnM view 256
16.1.3.4.1 Right to win 256
16.1.3.4.2 Strategic choices 257
16.1.3.4.3 Weaknesses and competitive threats 257

16.1.4 BECTON, DICKINSON AND COMPANY (BD) 258
16.1.4.1 Business overview 258
16.1.4.2 Products offered 260
16.1.4.3 Recent developments 260
16.1.4.3.1 Expansions 260
16.1.4.4 MnM view 261
16.1.4.4.1 Right to win 261
16.1.4.4.2 Strategic choices 261
16.1.4.4.3 Weaknesses and competitive threats 261
16.1.5 NEOGEN CORPORATION 262
16.1.5.1 Business overview 262
16.1.5.2 Products/Services offered 263
16.1.5.3 Recent developments 264
16.1.5.3.1 Product/Service launches and approvals 264
16.1.5.3.2 Deals 265
16.1.5.4 MnM view 265
16.1.5.4.1 Right to win 265
16.1.5.4.2 Strategic choices 265
16.1.5.4.3 Weaknesses and competitive threats 265
16.1.6 QIAGEN 266
16.1.6.1 Business overview 266
16.1.6.2 Products offered 267
16.1.6.3 Recent developments 268
16.1.6.3.1 Product launches 268
16.1.7 BIO-RAD LABORATORIES, INC. 269
16.1.7.1 Business overview 269
16.1.7.2 Products/Services offered 270
16.1.7.3 Recent developments 271
16.1.7.3.1 Product launches 271
16.1.8 BRUKER 272
16.1.8.1 Business overview 272
16.1.8.2 Products/Services offered 273
16.1.8.3 Recent developments 274
16.1.8.3.1 Deals 274
16.1.9 SHIMADZU CORPORATION 275
16.1.9.1 Business overview 275
16.1.9.2 Products/Services offered 276
16.1.9.3 Recent developments 277
16.1.9.3.1 Product/Service launches and approvals 277
16.1.9.3.2 Expansions 277
16.1.10 CHARLES RIVER LABORATORIES 278
16.1.10.1 Business overview 278
16.1.10.2 Products/Services offered 279
16.1.10.3 Recent developments 280
16.1.10.3.1 Product/Service launches and approvals 280
16.1.11 EUROFINS SCIENTIFIC 281
16.1.11.1 Business overview 281
16.1.11.2 Products/Services offered 282
16.1.11.3 Recent developments 283
16.1.11.3.1 Deals 283
16.1.12 IDEXX 284
16.1.12.1 Business overview 284
16.1.12.2 Products/Services offered 285
16.1.12.3 Recent developments 286
16.1.12.3.1 Product/Service launches and approvals 286
16.2 OTHER PLAYERS 287
16.2.1 HARDY DIAGNOSTICS 287
16.2.2 CHARM SCIENCES 288
16.2.3 MICROBIOLOGICS 289
16.2.4 LIOFILCHEM S.R.L. 290
16.2.5 R-BIOPHARM 291
16.2.6 ROMER LABS DIVISION HOLDING 292
16.2.7 HYGIENA LLC 293
16.2.8 HIMEDIA LABORATORIES 294
16.2.9 CONDALAB 295
16.2.10 E&O LABORATORIES LTD 296
16.2.11 MAST GROUP LTD. 297
16.2.12 MEDICAL WIRE & EQUIPMENT 298
16.2.13 HACH 299
17 RESEARCH METHODOLOGY 300
17.1 RESEARCH DATA 300
17.2 RESEARCH APPROACH 300
17.2.1 SECONDARY DATA 301
17.2.1.1 Key secondary sources 301
17.2.1.2 Key data from secondary sources 302
17.2.2 PRIMARY DATA 303
17.2.2.1 Primary sources 303
17.2.2.2 Key data from primary sources 304
17.2.2.3 Key industry insights 305
17.2.2.4 Breakdown of primary interviews 306
17.3 MARKET SIZE ESTIMATION 306
17.3.1 BOTTOM-UP APPROACH 307
17.3.1.1 Approach 1: Company revenue estimation approach 307
17.3.1.2 Approach 2: Presentations of companies and primary interviews 307
17.3.1.3 Growth forecast 308
17.3.1.4 CAGR projections 308
17.3.2 TOP-DOWN APPROACH 309
17.4 DATA TRIANGULATION 310
17.5 MARKET SHARE ASSESSMENT 310
17.6 RESEARCH ASSUMPTIONS 311
17.6.1 PARAMETRIC ASSUMPTIONS 311
17.7 RESEARCH LIMITATIONS 311
17.8 RISK ASSESSMENT 312
18 APPENDIX 313
18.1 DISCUSSION GUIDE 313
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 317
18.3 CUSTOMIZATION OPTIONS 319
18.4 RELATED REPORTS 319
18.5 AUTHOR DETAILS 320

LIST OF TABLES

TABLE 1 INCLUSIONS AND EXCLUSIONS 32
TABLE 2 US: FOOD RECALLS IN AND REASONS, 2023 44
TABLE 3 US: FOOD RECALLS, BY SPECIES, 2023 44
TABLE 4 TOP INNOVATIONS IN FOOD TESTING TECHNOLOGY 47
TABLE 5 INTERCONNECTED MARKETS 50
TABLE 6 KEY MOVES AND STRATEGIC FOCUS 51
TABLE 7 IMPACT OF PORTER’S FIVE FORCES ON MICROBIOLOGY TESTING MARKET 53
TABLE 8 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2023-2030 55
TABLE 9 NORTH AMERICA: MACROECONOMIC INDICATORS 56
TABLE 10 EUROPE: MACROECONOMIC INDICATORS 56
TABLE 11 ASIA PACIFIC: MACROECONOMIC INDICATORS 56
TABLE 12 LATIN AMERICA: MACROECONOMIC INDICATORS 57
TABLE 13 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 57
TABLE 14 MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 60
TABLE 15 AVERAGE SELLING PRICING TREND OF MICROBIOLOGY TESTING, BY PRODUCT, 2024–2026 (USD) 61
TABLE 16 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY KEY PLAYER, 2024–2026 (USD) 61
TABLE 17 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS,
BY REGION, 2024–2026 (USD) 62
TABLE 18 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD MILLION) 63
TABLE 19 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD MILLION) 63
TABLE 20 MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS,
2026–2027 64
TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 68
TABLE 22 LIST OF MAJOR PATENTS PERTAINING TO MICROBIOLOGY TESTING MARKET, 2023–2025 74
TABLE 23 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 24 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 25 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 26 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 28 GLOBAL STANDARDS IN THE MICROBIOLOGY TESTING MARKET 80
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 84
TABLE 30 KEY BUYING CRITERIA, BY PRODUCT 84
TABLE 31 ADOPTION BARRIERS & INTERNAL CHALLENGES 85
TABLE 32 MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 86
TABLE 33 MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 89
TABLE 34 KEY INSTRUMENTS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 90
TABLE 35 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 91
TABLE 36 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 91
TABLE 37 NORTH AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 92
TABLE 38 EUROPE: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 92
TABLE 39 ASIA PACIFIC: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 93
TABLE 40 LATIN AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 93
TABLE 41 MICROBIOLOGY TESTING INCUBATORS MARKET, BY REGION,
2024–2031 (USD MILLION) 94
TABLE 42 NORTH AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 94
TABLE 43 EUROPE: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 95
TABLE 44 ASIA PACIFIC: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95
TABLE 45 LATIN AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 96
TABLE 46 MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION) 96
TABLE 47 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 97
TABLE 48 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97
TABLE 49 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97
TABLE 50 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 98
TABLE 51 COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION) 98
TABLE 52 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 99
TABLE 53 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99
TABLE 54 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 100
TABLE 55 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 100
TABLE 56 MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 101
TABLE 57 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 101
TABLE 58 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 101
TABLE 59 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 102
TABLE 60 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 102
TABLE 61 AUTOMATED CULTURE SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 103
TABLE 62 NORTH AMERICA: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 103
TABLE 63 EUROPE: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 104
TABLE 64 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 104
TABLE 65 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 105
TABLE 66 OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 105
TABLE 67 NORTH AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 106
TABLE 68 EUROPE: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106
TABLE 69 ASIA PACIFIC: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 107
TABLE 70 LATIN AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 107
TABLE 71 KEY REAGENTS & KITS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 108
TABLE 72 MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 109
TABLE 73 NORTH AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 74 EUROPE: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 75 ASIA PACIFIC: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 76 LATIN AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 77 KEY CONSUMABLES IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 112
TABLE 78 MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 113
TABLE 79 NORTH AMERICA: MICROBIOLOGY TESTING CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 80 EUROPE: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 114
TABLE 81 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES,
BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 82 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES,
BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 83 US: PHARMA INCUBATOR INSTALLED BASE VOLUME, 2024–2031 (UNITS) 116
TABLE 84 MICROBIOLOGY TESTING TECHNOLOGY MARKET, BY TECHNOLOGY TYPE,
2024–2031 (USD MILLION) 118
TABLE 85 TYPES OF TECHNOLOGIES USED IN VARIOUS TRADITIONAL MICROBIOLOGY METHODS (TMM) 119
TABLE 86 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY TYPE,
2024–2031 (USD MILLION) 120
TABLE 87 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY REGION,
2024–2031 (USD MILLION) 120
TABLE 88 NORTH AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 89 EUROPE: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 90 ASIA PACIFIC: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 91 LATIN AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 92 CULTURE METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 123
TABLE 93 NORTH AMERICA: CULTURE METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 123
TABLE 94 EUROPE: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 95 ASIA PACIFIC: CULTURE METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 124
TABLE 96 LATIN AMERICA: CULTURE METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 125
TABLE 97 MICROSCOPY METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 126
TABLE 98 NORTH AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 126
TABLE 99 EUROPE: MICROSCOPY METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 126
TABLE 100 ASIA PACIFIC: MICROSCOPY METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 101 LATIN AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 102 MANUAL COUNTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 128
TABLE 103 NORTH AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 104 EUROPE: MANUAL COUNTING METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 105 ASIA PACIFIC: MANUAL COUNTING METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 106 LATIN AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 130
TABLE 107 STAINING TECHNIQUES MARKET, BY REGION, 2024–2031 (USD MILLION) 131
TABLE 108 NORTH AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 131
TABLE 109 EUROPE: STAINING TECHNIQUES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 131
TABLE 110 ASIA PACIFIC: STAINING TECHNIQUES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 132
TABLE 111 LATIN AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 132
TABLE 112 OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY REGION,
2024–2031 (USD MILLION) 133
TABLE 113 NORTH AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 114 EUROPE: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 115 ASIA PACIFIC: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 116 LATIN AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 117 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY METHODS (RMM) 136
TABLE 118 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 119 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY REGION,
2024–2031 (USD MILLION) 137
TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 121 EUROPE: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 124 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION,
2024–2031 (USD MILLION) 140
TABLE 125 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 126 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 127 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 128 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 129 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY REGION, 2024–2031 (USD MILLION) 143
TABLE 130 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 131 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 132 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 133 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 134 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 135 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 136 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 137 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 138 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 139 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION,
2024–2031 (USD MILLION) 149
TABLE 140 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 141 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 142 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 143 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 144 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 153
TABLE 145 BACTERIAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 154
TABLE 146 NORTH AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 147 EUROPE: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 148 ASIA PACIFIC: BACTERIAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 149 LATIN AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 150 VIRAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 151 NORTH AMERICA: VIRAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 152 EUROPE: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 153 ASIA PACIFIC: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 154 LATIN AMERICA: VIRAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 157
TABLE 155 FUNGAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 158
TABLE 156 NORTH AMERICA: FUNGAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 157 EUROPE: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 158 ASIA PACIFIC: FUNGAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 159
TABLE 159 LATIN AMERICA: FUNGAL TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 159
TABLE 160 OTHER PATHOGEN TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 160
TABLE 161 NORTH AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 160
TABLE 162 EUROPE: OTHER PATHOGEN TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 160
TABLE 163 ASIA PACIFIC: OTHER PATHOGEN TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 161
TABLE 164 LATIN AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 161
TABLE 165 MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 163
TABLE 166 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 167 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 168 EUROPE: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 169 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 170 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 171 MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES,
BY REGION, 2024–2031 (USD MILLION) 166
TABLE 172 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 173 EUROPE: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 174 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 175 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 176 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING,
BY REGION, 2024–2031 (USD MILLION) 169
TABLE 177 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 178 EUROPE: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 179 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 180 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 181 MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 171
TABLE 182 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 183 EUROPE: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 184 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 185 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 186 MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 174
TABLE 187 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 188 EUROPE: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 189 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 190 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 191 MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 178
TABLE 192 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 179
TABLE 193 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 180
TABLE 194 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 180
TABLE 195 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 180
TABLE 196 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY END USERS,
2024–2031 (USD MILLION) 181
TABLE 197 US: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 182
TABLE 198 US: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 182
TABLE 199 US: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 182
TABLE 200 US: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 183
TABLE 201 CANADA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 184
TABLE 202 CANADA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 184
TABLE 203 CANADA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 185
TABLE 204 CANADA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 185
TABLE 205 EUROPE: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 186
TABLE 206 EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 186
TABLE 207 EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 187
TABLE 208 EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 187
TABLE 209 EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 188
TABLE 210 GERMANY: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 189
TABLE 211 GERMANY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 189
TABLE 212 GERMANY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 189
TABLE 213 GERMANY: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 190
TABLE 214 UK: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 191
TABLE 215 UK: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 191
TABLE 216 UK: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 191
TABLE 217 UK: MICROBIOLOGY TESTING MARKET, BY END USERS,
2024–2031 (USD MILLION) 192
TABLE 218 FRANCE: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 193
TABLE 219 FRANCE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 193
TABLE 220 FRANCE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 193
TABLE 221 FRANCE: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 194
TABLE 222 ITALY: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 195
TABLE 223 ITALY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 195
TABLE 224 ITALY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 195
TABLE 225 ITALY: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 196
TABLE 226 SPAIN: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 197
TABLE 227 SPAIN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 197
TABLE 228 SPAIN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 197
TABLE 229 SPAIN: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 198
TABLE 230 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 198
TABLE 231 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 199
TABLE 232 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 199
TABLE 233 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 200
TABLE 234 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 202
TABLE 235 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 202
TABLE 236 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 203
TABLE 237 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 203
TABLE 238 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 204
TABLE 239 CHINA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 205
TABLE 240 CHINA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 205
TABLE 241 CHINA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 205
TABLE 242 CHINA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 243 JAPAN: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 207
TABLE 244 JAPAN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 207
TABLE 245 JAPAN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 207
TABLE 246 JAPAN: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 208
TABLE 247 INDIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 209
TABLE 248 INDIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 209
TABLE 249 INDIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 209
TABLE 250 INDIA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 210
TABLE 251 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 211
TABLE 252 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 211
TABLE 253 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 211
TABLE 254 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 212
TABLE 255 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 213
TABLE 256 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 213
TABLE 257 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 213
TABLE 258 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 214
TABLE 259 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 214
TABLE 260 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 215
TABLE 261 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 215
TABLE 262 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 263 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 217
TABLE 264 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 217
TABLE 265 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 217
TABLE 266 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 218
TABLE 267 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 218
TABLE 268 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 219
TABLE 269 BRAZIL: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 219
TABLE 270 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 219
TABLE 271 BRAZIL: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 220
TABLE 272 MEXICO: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 221
TABLE 273 MEXICO: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 221
TABLE 274 MEXICO: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE,
2024–2031 (USD MILLION) 221
TABLE 275 MEXICO: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 222
TABLE 276 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 222
TABLE 277 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 223
TABLE 278 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 223
TABLE 279 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 224
TABLE 280 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 225
TABLE 281 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 225
TABLE 282 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 225
TABLE 283 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY END USER,
2024–2031 (USD MILLION) 226
TABLE 284 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 227
TABLE 285 MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION 230
TABLE 286 REGIONAL FOOTPRINT, 2025 234
TABLE 287 PRODUCT FOOTPRINT, 2025 235
TABLE 288 TECHNOLOGY FOOTPRINT 235
TABLE 289 END USER FOOTPRINT, 2025 236
TABLE 290 LIST OF STARTUPS/SMES, 2025 239
TABLE 291 MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2), 2025 239
TABLE 292 MICROBIOLOGY TESTING MARKET COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2), 2025 240
TABLE 293 MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–DECEMBER 2025 242
TABLE 294 MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2022–DECEMBER 2025 243
TABLE 295 MICROBIOLOGY TESTING MARKET: EXPANSION, JANUARY 2022–DECEMBER 2025 243
TABLE 296 BIOMÉRIEUX: COMPANY OVERVIEW 244
TABLE 297 BIOMÉRIEUX: PRODUCTS OFFERED 245
TABLE 298 BIOMÉRIEUX: PRODUCT LAUNCHES AND APPROVALS 246
TABLE 299 BIOMÉRIEUX: DEALS 247
TABLE 300 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 249
TABLE 301 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 250
TABLE 302 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS 251
TABLE 303 MERCK KGAA: COMPANY OVERVIEW 253
TABLE 304 MERCK KGAA: PRODUCTS/SERVICES OFFERED 254
TABLE 305 MERCK KGAA: PRODUCT LAUNCHES 255
TABLE 306 MERCK KGAA: DEALS 255
TABLE 307 MERCK KGAA: EXPANSIONS 256
TABLE 308 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 258
TABLE 309 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 260
TABLE 310 BECKTON, DICKINSON AND COMPANY: EXPANSIONS 260
TABLE 311 NEOGEN CORPORATION: COMPANY OVERVIEW 262
TABLE 312 NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED 263
TABLE 313 NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES 264
TABLE 314 NEOGEN CORPORATION: DEALS 265
TABLE 315 QIAGEN: COMPANY OVERVIEW 266
TABLE 316 MCKESSON CORPORATION: PRODUCTS OFFERED 267
TABLE 317 QIAGEN N.V.: PRODUCT LAUNCHES 268
TABLE 318 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 269
TABLE 319 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 270
TABLE 320 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES 271
TABLE 321 BRUKER: COMPANY OVERVIEW 272
TABLE 322 BRUKER: PRODUCTS/SERVICES OFFERED 273
TABLE 323 BRUKER: DEALS 274
TABLE 324 SHIMADZU CORPORATION: COMPANY OVERVIEW 275
TABLE 325 SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED 276
TABLE 326 SHIMADZU CORPORATION: PRODUCT/SERVICE LAUNCHES AND APPROVALS 277
TABLE 327 SHIMADZU CORPORATION: EXPANSIONS 277
TABLE 328 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 278
TABLE 329 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 279
TABLE 330 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES 280
TABLE 331 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 281
TABLE 332 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 282
TABLE 333 EUROFINS SCIENTIFIC: DEALS 283
TABLE 334 IDEXX: COMPANY OVERVIEW 284
TABLE 335 IDEXX: PRODUCTS/SERVICES OFFERED 285
TABLE 336 IDEXX: PRODUCT/SERVICE LAUNCHES AND APPROVALS 286
TABLE 337 HARDY DIAGNOSTICS: COMPANY OVERVIEW 287
TABLE 338 CHARM SCIENCES: COMPANY OVERVIEW 288
TABLE 339 MICROBIOLOGICS: COMPANY OVERVIEW 289
TABLE 340 LIOFILCHEM S.R.L. : COMPANY OVERVIEW 290
TABLE 341 R-BIOPHARM: COMPANY OVERVIEW 291
TABLE 342 ROMER LABS DIVISION HOLDING: COMPANY OVERVIEW 292
TABLE 343 HYGIENA LLC: COMPANY OVERVIEW 293
TABLE 344 HIMEDIA LABORATORIES: COMPANY OVERVIEW 294
TABLE 345 CONDALAB: COMPANY OVERVIEW 295
TABLE 346 E&O LABORATORIES LTD: COMPANY OVERVIEW 296
TABLE 347 MAST GROUP LTD.: COMPANY OVERVIEW 297
TABLE 348 MEDICAL WIRE & EQUIPMENT: COMPANY OVERVIEW 298
TABLE 349 HACH: COMPANY OVERVIEW 299
TABLE 350 MICROBIOLOGY TESTING MARKET: KEY DATA FROM PRIMARY SOURCES 304
TABLE 351 RISK ASSESSMENT 312

LIST OF FIGURES

FIGURE 1 MICROBIOLOGY TESTING MARKET SEGMENTATION 31
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 34
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOLOGY TESTING MARKET, 2022–2025 35
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF MICROBIOLOGY TESTING MARKET 35
FIGURE 5 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MICROBIOLOGY TESTING MARKET 36
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 37
FIGURE 7 GROWING NEED FOR CONTAMINATION CONTROL TO DRIVE MARKET 38
FIGURE 8 REAGENT & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 38
FIGURE 9 TRADITIONAL MICROBIOLOGY METHODS (TMM) TO LEAD MARKET DURING FORECAST PERIOD 39
FIGURE 10 BACTERIAL TESTING TO CONTINUE LEAD SIGNIFICANTLY
DURING FORECAST PERIOD 39
FIGURE 11 PHARMACEUTICAL & BIOTECH COMPANIES TO COMMAND LARGEST SHARE AMONG END USERS DURING FORECAST PERIOD 40
FIGURE 12 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40
FIGURE 13 MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 14 PRODUCTS RECALLED GLOBALLY, 2012–2022 43
FIGURE 15 MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 52
FIGURE 16 MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS 58
FIGURE 17 MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS 59
FIGURE 18 MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS 60
FIGURE 19 MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN MICROBIOLOGY TESTING MARKET 66
FIGURE 21 PATENT ANALYSIS FOR MICROBIOLOGY TESTING,
JANUARY 2016–DECEMBER 2025 73
FIGURE 22 MARKET POTENTIAL OF AI IN MICROBIOLOGY TESTING MARKET 75
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 83
FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT 84
FIGURE 25 NORTH AMERICA: MICROBIOLOGY TESTING MARKET SNAPSHOT 179
FIGURE 26 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET SNAPSHOT 201
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 229
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 230
FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 231
FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 233
FIGURE 31 COMPANY FOOTPRINT, 2025 234
FIGURE 32 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 238
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK
BETA OF KEY VENDORS, 2025 240
FIGURE 34 EV/EBITDA OF KEY VENDORS, 2025 241
FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS 241
FIGURE 36 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 245
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 250
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2024) 254
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 259
FIGURE 40 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024) 263
FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2024) 267
FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 270
FIGURE 43 BRUKER: COMPANY SNAPSHOT (2024) 273
FIGURE 44 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 276
FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 279
FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 282
FIGURE 47 IDEXX: COMPANY SNAPSHOT (2024) 285
FIGURE 48 MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY 300
FIGURE 49 KEY DATA FROM SECONDARY SOURCES 302
FIGURE 50 PRIMARY SOURCES 303
FIGURE 51 INSIGHTS FROM INDUSTRY EXPERTS 305
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 306
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 306
FIGURE 54 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 307
FIGURE 55 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 308
FIGURE 56 MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH 309
FIGURE 57 DATA TRIANGULATION METHODOLOGY 310
FIGURE 58 MICROBIOLOGY TESTING MARKET: RESEARCH ASSUMPTIONS 311

---

---